• E-mail
• Print
• Comment
• Font Size
• Digg
• del.icio.us
• Discuss article

China Health Holding Announces Scientific Advisory Board

Posted on: Wednesday, 28 December 2005, 06:00 CST

China Health Holding (NASD OTCBB: CHHH), a developer, marketer and manufacturer of natural herbal supplement products based on traditional Chinese Medicine, announced today the formation of its Scientific Advisory Board.

The Company has attracted knowledgeable, experienced, honorable and successful directors, advisors and management to guide its development stages. The Company is currently in discussions with and actively recruiting world class scientific and pharmaceutical and TCM (Traditional Chinese Medicine) specialists, as well as prominent, highly experienced business advisors to join the Company's scientific advisor board and board of directors and world-class management team.

CHHH OTCBB Scientific Advisory Board :

Professor Yu, Edward (X.F.): Chief TCM Advisor

Instrumental in the development of numerous natural products for China Health Holding, Inc., Professor Yu was elected to the Board and appointed Vice President in 2004. Past President and Director of Beijing's Taoist Tantric & Toltec Research & Development Centre, he is currently a Research Scientific Consultant at the city's Central TCM ( Traditional Chinese Medicine) Research & Development Institute. Presently a professor in the Department of Philosophy, Professor Yu teaches Taoism, Taoist Medicine and Indian classical philosophy and religion at Beijing's University of CCCP.

Dr. Zhou, Joseph (J.R.) - Chief Medical Advisor

Dr. Zhou, Joseph (J.R.) is an Assistant Professor of Surgery at Harvard Medical School and the Director of Nutrition/Metabolism Laboratory at Beth Israel Deaconess Medical Center. Dr. Zhou received his Ph.D. in nutritional Sciences from University of Illinois in 1994 and his postdoctoral training in bio-nutrition and cancer prevention at Beth Israel deaconess Medical Center, Harvard Medical School. Dr. Zhou is a national and international known expert in nutrition and cancer prevention. Dr. Zhou also actively participates in several review panels and study sections in National Institutes of Health and other scientific foundations.

Dr. Ma, Yua-Chun : Chief Scientific Advisor

Dr. Ma, the President/CEO of Canadian Phytopharmceutical, specializes in Research & development and manufacturing of botanical and natural pharmaceutical products. He received an M.Sc. at HuBei University, PR China and Ph.D. in Pharmaceutical Science at the University of Portsmouth, England. He served as senior consultant for Health Canada and Agriculture Canada and also for the National Research Council of Canada in R&D on standardization for Natural Health Products in BC Canada.

Professor Fan, Zheng-lun : Chief Scientific Advisor

In 1982, Professor Zheng-Lun Fan acquired his MSC in Liao-Ning College of Traditional Chinese Medicine. During the past five years, he has been a Research Fellow at Cui Yue-li Research Center of Traditional Chinese Medicine. Professor Fan also is a MSC, Professor, Chief Physician Research Fellow at Cui Yue-li Research Center of Traditional Chinese Medicine, Beijing, P.R. China. Prof. Fan is an expert of Chinese medicine at the national level in P. R. China and he has practiced Chinese medicine for more than 40 years.

About China Health Holding, Inc.

China Health Holding, Inc., incorporated in 2002, is a developer, marketer and manufacturer of Innovative Enhanced Traditional Chinese Medicinal herbal supplement product lines. The Company's product lines also include dietary food supplements that are helpful in strengthening the immune system and cardio-cerebral vascular function as well as promoting overall physical and mental health.

The Company plans to introduce a line of natural skin care and cosmetic products as well as to develop new products based on its knowledge of traditional Chinese medical practice. Please visit China Health Holding, Inc.'s website www.chinahealthholding.com for Company Profile details.

Safe Harbor

To the extent that statements in the press releases are not strictly historical, including statements as to revenue projections, business strategy, outlook, objectives, future milestones, plans, intentions, goals, future financial conditions, future collaboration agreements, the success of the Company's development, events conditioned on stockholder or other approval, or otherwise as to future events, such statements are forward-looking, All forward-looking statements, whether written or oral, and whether made by or on behalf of the company, are expressly qualified by the cautionary statements and any other cautionary statements which may accompany the forward-looking statements, and are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. The forward-looking statements contained in this release are subject to certain risks and uncertainties that could cause actual results to differ materially from the statements made. Other important factors that could cause actual results to differ materially include the following: business conditions and the amount of growth in the Company's industry and general economy; competitive factors; ability to attract and retain personnel; the price of the Company's stock; and the risk factors set forth from time to time in the Company's SEC reports, including but not limited to its annual report on Form 10-KSB; its quarterly reports on Forms 10-QSB; and any reports on Form 8-K. In addition, the company disclaims any obligation to update or correct any forward-looking statements in all the Company's press releases to reflect events or circumstances after the date hereof.

Source: Business Wire

More News in this Category